Literature DB >> 30693541

Sleep duration and patterns in Chinese patients with diabetes: A meta-analysis of comparative studies and epidemiological surveys.

Fei Wang1,2, Ines H I Chow2, Lu Li3, Xiao-Hong Li4, Chee H Ng5, Gabor S Ungvari6,7, Ai-Hong Wang8, Fu-Jun Jia1, Ye Zhang9, Yu-Tao Xiang2.   

Abstract

PURPOSE: A meta-analysis on sleep duration and patterns in patients with diabetes in China. DESIGN AND METHODS: Two investigators independently carried out a systematic literature search in both international and Chinese databases.
FINDINGS: A total of 47 studies with 98 911 patients were included. The pooled mean sleep duration was 7.15 hours/day in patients with diabetes and 7.49 hours/day in healthy controls. The estimated percentage of short sleep duration of less than 6 hours/day was 23.0% in patients with diabetes and 12.3% in healthy controls, while the proportion of short sleep duration of less than 7 hours/day was 38.0% in patients with diabetes and 14.1% in healthy controls. PRACTICE IMPLICATIONS: Short sleep duration was common in Chinese patients with diabetes.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  China; diabetes; meta-analysis; sleep duration; sleep patternPROSPERO registration number: CRD42017077009

Mesh:

Year:  2019        PMID: 30693541     DOI: 10.1111/ppc.12353

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  2 in total

1.  Association Between Sleep Duration and Albuminuria in Patients with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China.

Authors:  Xueyu Li; Kaushik Chattopadhyay; Xingjun Qian; Jingjia Yu; Miao Xu; Li Li; Jing Sun; Jialin Li
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-30       Impact factor: 3.249

2.  Association Between Nocturnal Sleep Duration and Obesity Indicators Among People with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China.

Authors:  Miao Xu; Kaushik Chattopadhyay; Xingjun Qian; Jialin Li; Xueyu Li; Jing Sun; Li Li
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-03       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.